{"id":"W1751016438","doi":"10.1007/s00277-015-2478-9","title":"Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"Celgene; H. Lundbeck A/S; Teva Pharmaceutical Industries","keywords":"Bendamustine; Medicine; Internal medicine; Mantle cell lymphoma; Neutropenia; Tolerability; Gastroenterology; Rituximab; Nausea; Adverse effect; Progressive disease; Salvage therapy; Phases of clinical research; Surgery; Febrile neutropenia; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002853883,0.0001988275,0.00108317,0.0001752921,0.00003843868,0.000002737615,0.00008011855,0.0001062211,0.00001977843],"category_scores_gemma":[0.0001078283,0.0001472214,0.00005235221,0.0001891734,0.0001698101,0.00004400576,0.0001087339,0.0000690938,0.000003276376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002841706,"about_ca_system_score_gemma":0.0001477303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003261663,"about_ca_topic_score_gemma":0.000116871,"domain_scores_codex":[0.9984863,0.00008874783,0.0006121488,0.0003301473,0.0002304489,0.0002521489],"domain_scores_gemma":[0.9988753,0.0002303771,0.0002069191,0.0003661266,0.0001584269,0.0001628784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02029063,0.3652263,0.5977226,0.0005260694,0.0003712944,0.000993893,0.006887611,0.000007018489,0.0003781143,0.0006949039,0.001795624,0.005105958],"study_design_scores_gemma":[0.5030619,0.1415379,0.282052,0.0004871275,0.0004572058,0.0005783626,0.004057001,0.0001041784,0.06626119,0.000233752,0.0007556962,0.0004137746],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963431,0.0009806614,9.92014e-7,0.001101432,0.00003909409,0.0007530625,0.00001679224,0.00001691006,0.0007478992],"genre_scores_gemma":[0.9996017,0.00006161081,0.0001152419,0.0001130708,0.000007323365,0.00002969951,0.00002203877,0.00001584326,0.00003348269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4827712,"threshold_uncertainty_score":0.6003514,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0478569194042865,"score_gpt":0.329224975148347,"score_spread":0.2813680557440605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}